Literature DB >> 22887978

Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome.

Yanqin Zhang1, Fang Wang, Jie Ding, Hongwen Zhang, Dan Zhao, Lixia Yu, Huijie Xiao, Yong Yao, Xuhui Zhong, Suxia Wang.   

Abstract

Autosomal recessive Alport syndrome (ARAS) results from mutations in the COL4A3 or COL4A4 gene. We analyzed the genotype and phenotype of 17 unrelated Chinese patients with ARAS. Clinical data were reviewed. All coding exons of COL4A3 and COL4A4 genes were PCR-amplified and sequenced from genomic DNA. We identified pathologic mutations in all patients, giving a mutation detection rate of 100%, with 82% in COL4A3 gene and 18% in COL4A4 gene. Sixteen novel mutations in COL4A3 gene and four novel mutations in COL4A4 gene were identified. Furthermore, a previously reported in-frame deletion mutation (40_63del24) in exon 1 of the COL4A3 gene was found in four patients in our study. A single 40_63del24 mutation in COL4A3 seems to result in mild or no renal manifestations, whereas the homozygous state of 40_63del24 in COL4A3 gene or compound heterozygous mutation of 40_63del24 plus another nonsense or frameshift mutation in COL4A3 gene seems to result severe ARAS with hearing loss. Half of the probands' parents had hematuria with or without mild proteinuria. Therefore, we recommend that ARAS be considered when a patient has a positive family history of hematuria, and screening for COL4A3 mutations firstly may be an efficient strategy for molecular diagnosis of ARAS.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22887978     DOI: 10.1002/ajmg.a.35528

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.

Authors:  Asli Subasioglu Uzak; Bulent Tokgoz; Munis Dundar; Mustafa Tekin
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-08

2.  Natural history of genetically proven autosomal recessive Alport syndrome.

Authors:  Masafumi Oka; Kandai Nozu; Hiroshi Kaito; Xue Jun Fu; Koichi Nakanishi; Yuya Hashimura; Naoya Morisada; Kunimasa Yan; Masafumi Matsuo; Norishige Yoshikawa; Igor Vorechovsky; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

3.  Renal, auricular, and ocular outcomes of Alport syndrome and their current management.

Authors:  Yanqin Zhang; Jie Ding
Journal:  Pediatr Nephrol       Date:  2017-09-01       Impact factor: 3.714

4.  A case of mild phenotype Alport syndrome caused by COL4A3 mutations.

Authors:  Masafumi Kamijo; Mineaki Kitamura; Kumiko Muta; Tadashi Uramatsu; Yoko Obata; Kandai Nozu; Hiroshi Kaito; Kazumoto Iijima; Hiroshi Mukae; Tomoya Nishino
Journal:  CEN Case Rep       Date:  2017-08-30

5.  Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.

Authors:  Yanqin Zhang; Fang Wang; Jie Ding; Hongwen Zhang; Xiaoyu Liu; Suxia Wang; Huijie Xiao; Yong Yao; Jingcheng Liu; Xuhui Zhong; Na Guan; Baige Su; Guohong Wu; Lixia Yu
Journal:  Pediatr Nephrol       Date:  2015-08-07       Impact factor: 3.714

6.  Self-Assembled Peptide-Based Biocomposites for Near-Infrared Light Triggered Drug Release to Tumor Cells.

Authors:  Rachel E Daso; Ipsita A Banerjee
Journal:  Biotechnol J       Date:  2020-09-15       Impact factor: 4.677

7.  Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease.

Authors:  Fujun Lin; Fan Bian; Jun Zou; Xiangru Wu; Jianping Shan; Wei Lu; Yao Yao; Gengru Jiang; Daniel Philip Gale
Journal:  BMC Nephrol       Date:  2014-11-07       Impact factor: 2.388

8.  Alport syndrome cold cases: Missing mutations identified by exome sequencing and functional analysis.

Authors:  Chiara Chiereghin; Michela Robusto; Antonio Mastrangelo; Pierangela Castorina; Giovanni Montini; Marisa Giani; Stefano Duga; Rosanna Asselta; Giulia Soldà
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

9.  Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.

Authors:  Yanqin Zhang; Jie Ding; Hongwen Zhang; Yong Yao; Huijie Xiao; Suxia Wang; Fang Wang
Journal:  Mol Genet Genomic Med       Date:  2019-03-18       Impact factor: 2.183

10.  A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.

Authors:  Ron Korstanje; Christina R Caputo; Rosalinda A Doty; Susan A Cook; Roderick T Bronson; Muriel T Davisson; Jeffrey H Miner
Journal:  Kidney Int       Date:  2014-02-12       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.